Share to Facebook Share to Twitter Share to LinkedIn Pinterest Email

Einstein Image: Spike Protein

Image credit: Jeffrey Bonanno, Ph.D.

The human antibodies that best neutralize the novel coronavirus bind to its spike protein. To develop antibody therapies, the laboratory of Steven Almo, Ph.D., needed to know where the best-neutralizing antibodies bind to the protein. Graduate students Natalia Herrera and Nicholas Morano obtained spike protein by expressing its gene in mammalian cells. The New York Structural Biology Center (NYSBC) then obtained cryo-electron microscopy images of ~50,000 particles of the protein.

Ed Eng (NYSBC) and Jeffrey Bonanno, Ph.D., research assistant professor in Dr. Almo’s lab, used computer programs to rapidly reconstruct those images into a molecular envelope (gray area), allowing the researchers to generate a high-resolution model of the protein’s amino-acid strands (represented as blue, red, and green ribbons). Of greatest interest in this structural model of a spike protein is the top part: the “receptor-binding domain” that latches onto the ACE2 receptors of human cells and is targeted by neutralizing antibodies.

Share to Facebook Share to Twitter Share to LinkedIn Share to Pinterest Email

More From Einstein

Prize for Cancer Research
The Latest on COVID-19 Research
Stand By Me: Ph.D. Mentoring
Welcoming the Class of 2024
Finding a Home at Einstein
The Role of Autophagy in Aging
Diversity in Medicine Scholarships

Content

Research Notes

Share

Share to Facebook Share to Twitter Share to LinkedIn Email

Past Issues

Download Magazine

Search

Subscribe